A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response to immunotherapy in patients with metastatic non-small cell lung ...
An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
An artificial intelligence (AI) model developed by researchers at The University of Texas MD Anderson Cancer Center ...
A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types ...
An AI model applied to pathology slides accurately predicts immunotherapy response in patients with metastatic non-small cell ...
In a National Institutes of Health (NIH)-funded study, researchers developed a cancer assessment tool that can identify high-risk patients and the tumor cells linked to that risk. The model, called ...
Using a historical data set from UT MD Anderson, Path-IO separated patients into high-risk and low-risk groups. Patients in ...
A research team led by The Hong Kong University of Science and Technology (HKUST) has developed a pioneering artificial ...
aNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, ...
SAN DIEGO – While oncologists may not yet be entirely comfortable using next-generation artificial intelligence tools to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results